Clinicians began exploring this approach for a few reasons: Not everyone needs aggressive appetite suppression to improve metabolic health Some people are more sensitive to GLP-1 medications Side effects often increase with higher doses Cost and long-term sustainability matter Women, in particular, started asking different questions
On the other hand, not all anti-diabetic drugs are free from potential side effects, which makes them not suitable for repositioning therapy of TC
The 2026 Clinical Obesity review found GLP-1 users running 2630% lower ferritin than comparison groups, and a separate analysis of 18,746 adults with type 2 diabetes found GLP-1 users had a 54% higher likelihood of lower ferritin than users of a different diabetes drug class
From niche medicine to mainstream gyms Five years ago, peptides were largely confined to specialist regenerative medicine clinics and the biohacking community
A.AndersonG.QuevedoJ.AlvesG
Alcohol is calorie-dense and impairs the GLP-1 appetite signal